Get notified when NMTC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Cfo (new) — CFO Ronald McClurg is retiring effective June 30, 2026, triggering a leadership transition at the financial helm.
NeuroOne CFO Ronald McClurg to retire; COO Christopher Volker promoted to CFO
Filed April 30, 2026 · Period ending April 24, 2026 · ~1 min read
Key Changes
-
high
CFO Ronald McClurg retiring effective June 30, 2026, will stay as Senior Advisor through year-end to ensure smooth transition of financial leadership duties.
Item 5.02 verify on EDGAR → -
high
COO Christopher Volker promoted to CFO effective July 1, 2026, bringing medtech finance experience from Abbott, Cardiovascular Systems, and St. Jude Medical including M&A and strategic planning expertise.
Item 5.02 verify on EDGAR → -
medium
Volker's base salary increased to $350,000 upon CFO appointment, with other employment terms unchanged.
Item 5.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade NMTC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify